+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Paracetamol Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4997604
  • Report
  • March 2020
  • Region: Global
  • 120 pages
  • Mordor Intelligence
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • BIOLOGICAL E
  • CFL PHARMA
  • CIPLA
  • Dr. Reddy's Laboratories
  • Genesis Biotec Inc.
  • GlaxoSmithKline plc
  • MORE
The Paracetamol market studied was projected to grow with a CAGR of nearly 4.3% over the forecast period. The major factor attributing to the growth of the market is the increase in the usage of paracetamol. Paracetamol is a pain reliever and a fever reducer. It is used to treat many conditions such as headache, muscle aches, arthritis, backache, toothaches, colds, and fevers. It relieves pain in mild arthritis but has no effect on the underlying inflammation and swelling of the joint. According to World Health Organization , globally, it has been estimated that prevalence among adults of current headache disorder is about 50%. Half to three quarters of adults aged 18–65 years in the world have had headache in year 2016 and, among those individuals, 30% or more have reported migraine. However the side effects caused by over usage of the drug is a drawback of the market growth.

Key Market Trends

Tablet Segment is Dominating the Paracetamol Market
  • Tablet segment holds the major share of the market as it is most commonly used form of paracetamol. Huge amounts of paracetamol are used to treat pain. According to University of Oxford, an estimate of the amount of paracetamol sold is just under 6,300 tonnes a year in the United Kingdom. That is 35 tonnes per million of population, 35 grams or 70 paracetamol tablets each, every year.
  • The other factors propelling the segment growth are the increasing chronic pains, headaches, fever. The rising awareness pertaining to the pain management solutions paracetamol extends, which basically, is an efficient analgesic, is the main factor that is fuelling the intake of paracetamol tablets, globally.
North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, high prevalence of fever, headaches, migraine in the region, established healthcare infrastructure are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and increase in number of research partnerships are some of the drivers expected to increase the market growth. In this region the United States has the maximum share due to supportive healthcare policies, high number of patients, and a developed healthcare market. According to the Migraine Research Foundation, more than 4 million adults experience chronic daily migraine with at least 15 migraine days per month in the United States alone. As per the statistics the the increasing patient pool and increasing disposable revenue in this country boosts the market growth of the region.

Competitive Landscape

The Paracetamol market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are GlaxoSmithKline plc, Teva Pharmaceuticals USA, Inc., Genesis Biotec Inc., Mallinckrodt Pharmaceuticals, GENO PHARMA, BIOLOGICAL E, CFL PHARMA, CIPLA, DR. REDDY'S LABS

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • 3 months of analyst support.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • BIOLOGICAL E
  • CFL PHARMA
  • CIPLA
  • Dr. Reddy's Laboratories
  • Genesis Biotec Inc.
  • GlaxoSmithKline plc
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Consumption of Paracetamol
4.2.2 Rising Prevalence of Conditions like Headaches, Flu etc.
4.2.3 Increasing Demand for Pain Management Drugs
4.3 Market Restraints
4.3.1 Side Effects of Overdosage of Paracetamol
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Dosage Form
5.1.1 Tablet
5.1.2 Capsules
5.1.3 Others
5.2 By Application
5.2.1 Headache and Fever
5.2.2 Cold and Cough
5.2.3 Muscle Cramps
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Rest of the World

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 GlaxoSmithKline plc
6.1.2 Mallinckrodt Pharmaceuticals
6.1.3 Sanofi
6.1.4 Sun Pharmaceuticals Industries ltd
6.1.5 Teva Pharmaceuticals USA, Inc
6.1.6 Dr. Reddy's Laboratories
6.1.7 BIOLOGICAL E
6.1.8 CFL PHARMA
6.1.9 CIPLA
6.1.10 Genesis Biotec Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GlaxoSmithKline plc
  • Mallinckrodt Pharmaceuticals
  • Sanofi
  • Sun Pharmaceuticals Industries ltd
  • Teva Pharmaceuticals USA, Inc
  • Dr. Reddy's Laboratories
  • BIOLOGICAL E
  • CFL PHARMA
  • CIPLA
  • Genesis Biotec Inc.
Note: Product cover images may vary from those shown
Adroll
adroll